Market Overview:
The global Jevtana market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of prostate cancer, increasing demand for targeted therapies, and growing awareness about Jevtana. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. On the basis of type, the global Jevtana market can be segmented into purity above 99% and other purities. The purity above 99% segment is expected to account for a larger share of this market during the forecast period. On the basis of application, this market can be divided into age below 65 years and age above 65 years. The age below 65 years segment is projected to account for a larger share of this market duringthe forecast period. Geographically, North America dominates thismarket followed by Europe and Asia Pacific .
Product Definition:
Jevtana is a chemotherapy drug used to treat prostate cancer.
Purity above 99%:
Purity above 99% is a new term in the market and it has gained popularity due to increasing demand for high purity products.
Other Purity:
Other purity is also known as the impurity of the drug that remains after purification of jevtana from its raw materials. It can be defined as a measure of drug potency remaining in a compound or mixture after extraction and before any further purification process. The other purity value is used to calculate concentration ratios which are then plugged into various formulas to obtain jevtana dosage formulae.
Application Insights:
The application segment includes the age below 65, above 65 and other applications. The age below 65 accounted for a revenue share of more than 50% in 2017. Increasing life expectancy has created a huge demand for medicines to treat diseases such as hypertension, diabetes mellitus, hyperlipidemia and cardiac disorders. Moreover, increasing healthcare spending is expected to fuel the market growth over the forecast period.
The above 65 application segment is anticipated to witness significant growth during the forecast period owing to an increase in prevalence of chronic diseases such as cancer and cardiovascular disorders that require treatment with medication throughout life span. According Jevtana Association of America Pvt., Ltd.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position through the forecast period owing to increasing geriatric population, which requires advanced healthcare services. Moreover, rising disposable income and improving lifestyle are contributing toward increased demand for medicines in this region.
North America accounted for a significant share of revenue in 2017 due to high purity grade drugs manufactured by major companies such as Pfizer Inc., and Novartis AG that are available at lower prices compared with other manufacturers. Furthermore, growing R&D activities by major pharmaceutical companies coupled with government support is anticipated to fuel growth over the forecast period.
Growth Factors:
- Increasing incidence of prostate cancer: The incidence of prostate cancer is increasing globally. This will drive the demand for Jevtana as a treatment option, thereby driving the growth of the market.
- Availability of reimbursement for Jevtana: Many countries are providing reimbursement for Jevtana, which will help to drive its uptake and growth in the market.
- Growing awareness about prostate cancer and its treatment options: There is growing awareness about prostate cancer and its treatment options among patients and healthcare professionals alike. This is helping to drive demand for Jevtana, which in turn is fuelling market growth.
- Launch of new products by competitors: Competitors are launching new products in order to capture a larger share of the market pie. This competitive landscape will help to fuel further growth in the Jevtana market over time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Jevtana Market Research Report
By Type
Purity above 99%, Other Purity
By Application
Age Below 65, Age Above 65
By Companies
Sanofi, Tapi Teva, Fuan Pharmaceutical Group, Fujian Yewpark Biological
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Jevtana Market Report Segments:
The global Jevtana market is segmented on the basis of:
Types
Purity above 99%, Other Purity
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Age Below 65, Age Above 65
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Tapi Teva
- Fuan Pharmaceutical Group
- Fujian Yewpark Biological
Highlights of The Jevtana Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity above 99%
- Other Purity
- By Application:
- Age Below 65
- Age Above 65
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Jevtana Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Jevtana is a meditation practice that helps practitioners focus and connect with their innermost thoughts and feelings.
Some of the key players operating in the jevtana market are Sanofi, Tapi Teva, Fuan Pharmaceutical Group, Fujian Yewpark Biological.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Jevtana Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Jevtana Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Jevtana Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Jevtana Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Jevtana Market Size & Forecast, 2018-2028
4.5.1 Jevtana Market Size and Y-o-Y Growth
4.5.2 Jevtana Market Absolute $ Opportunity
Chapter 5 Global Jevtana Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Jevtana Market Size Forecast by Type
5.2.1 Purity above 99%
5.2.2 Other Purity
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Jevtana Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Jevtana Market Size Forecast by Applications
6.2.1 Age Below 65
6.2.2 Age Above 65
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Jevtana Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Jevtana Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Jevtana Analysis and Forecast
9.1 Introduction
9.2 North America Jevtana Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Jevtana Market Size Forecast by Type
9.6.1 Purity above 99%
9.6.2 Other Purity
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Jevtana Market Size Forecast by Applications
9.10.1 Age Below 65
9.10.2 Age Above 65
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Jevtana Analysis and Forecast
10.1 Introduction
10.2 Europe Jevtana Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Jevtana Market Size Forecast by Type
10.6.1 Purity above 99%
10.6.2 Other Purity
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Jevtana Market Size Forecast by Applications
10.10.1 Age Below 65
10.10.2 Age Above 65
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Jevtana Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Jevtana Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Jevtana Market Size Forecast by Type
11.6.1 Purity above 99%
11.6.2 Other Purity
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Jevtana Market Size Forecast by Applications
11.10.1 Age Below 65
11.10.2 Age Above 65
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Jevtana Analysis and Forecast
12.1 Introduction
12.2 Latin America Jevtana Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Jevtana Market Size Forecast by Type
12.6.1 Purity above 99%
12.6.2 Other Purity
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Jevtana Market Size Forecast by Applications
12.10.1 Age Below 65
12.10.2 Age Above 65
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Jevtana Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Jevtana Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Jevtana Market Size Forecast by Type
13.6.1 Purity above 99%
13.6.2 Other Purity
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Jevtana Market Size Forecast by Applications
13.10.1 Age Below 65
13.10.2 Age Above 65
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Jevtana Market: Competitive Dashboard
14.2 Global Jevtana Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Tapi Teva
14.3.3 Fuan Pharmaceutical Group
14.3.4 Fujian Yewpark Biological
